Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-24 @ 11:25 PM
NCT ID:
NCT01064856
Eligibility Criteria:
Inclusion Criteria:
* Adult participants who had inadequate response to \>= 2 non-steroidal anti-inflammatories (NSAIDs)
* Participants who had arthritis or enthesitis or dactylitis plus: met spondyloarthritis clinical criteria
* Negative purified protein derivative (PPD) test and Chest X-Ray performed at Baseline Visit were Negative
* Ability to administer subcutaneous injections
* General good health
Exclusion Criteria:
* Prior anti-tumor necrosis factor (TNF) therapy
* Psoriasis or Psoriatic Arthritis
* Fulfillment of modified New York criteria for Ankylosing Spondylitis
* Recent infection requiring treatment
* Significant medical events or conditions that had put patients at risk for participation
* Female participants who were pregnant or breast-feeding or considering becoming pregnant during the study
* History of cancer, except successfully treated skin cancer
* Recent history of drug or alcohol abuse
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01064856
Study Brief:
Protocol Section:
NCT01064856